Life Insurance
Consensus Index

AI Consensus Fit Review

MassMutual Whole Life Insurance Fit Review for High Early Cash Value

MassMutual is a good fit for a buyer who prioritizes early cash value in whole life insurance, provided they can afford high limited-pay premiums and accept non-guaranteed dividends.

Research: 2026-09-207 usable platform responsesRead the methodology ↗

Share

Answer Capsule

MassMutual is a good fit for a buyer who prioritizes early cash value in whole life insurance, provided they can afford high limited-pay premiums and accept non-guaranteed dividends. Four of seven platforms named MassMutual during the ranking stage, and it finished with an average listed rank of 2.25 and a best rank of 1. The strongest reason to consider it is a purpose-built high-early-cash-value design plus participating whole life with paid-up additions and top-tier reported financial strength. The main limitation is that independent reviewers report competitors such as Penn Mutual and Lafayette Life often produce higher actual cash value in specific early-year windows, and MassMutual's paid-up-additions rider is described as comparatively rigid.

Research Snapshot

FieldDetail
Platform mentions in ranking stage4 of 7 platforms (deepseek, grok, openai, perplexity)
Share of included platform responses57.1%
Average listed rank2.25
Best listed rank1
Relevant product/model/planWhole Life Legacy High Early Cash Value (HECV); Whole Life Legacy 10 Pay; Whole Life Legacy 100 with paid-up additions rider
Overall use-case fitGood, with meaningful qualification
Research date2026-09-20

Why MassMutual Qualified for This Study

Questions This Section Answers

  • Is MassMutual a good choice for Whole Life Insurance for High Early Cash Value?
  • How many AI platforms recommended MassMutual for early cash value whole life insurance?

MassMutual qualified because four of the seven included platforms named it during ranking discovery, and it placed near the top of those lists. Its average listed rank was 2.25, with a best rank of 1 from both deepseek and perplexity [1]. The platform share was 57.1%, meaning a majority of included platforms treated it as a relevant carrier for this specific use case.

The qualification rests on three things the platforms agreed on: a dedicated high-early-cash-value product design, participating whole life with paid-up additions, and reported financial strength. MassMutual markets participating whole life and has a long operating history as a mutual insurer [1]. It reports ratings of A++ from A.M. Best, AA+ from Fitch, Aa3 from Moody's, and AA+ from S&P Global Ratings as of September 1, 2026, subject to change [3]. Independent reviewers repeat the same rating set and describe it as among the highest in any industry [4].

This is a niche fit review, not a broad company review. MassMutual's general reputation matters here only where it affects early cash value accumulation, policy design flexibility, or the buyer's ability to access cash value in the first years of a policy.

The Product, Model, Plan, or Service Most Relevant to Whole Life Insurance for High Early Cash Value

Questions This Section Answers

  • Which MassMutual whole life plan is best for a buyer who needs accessible cash value in the first 10 years?
  • Is MassMutual's Whole Life Legacy High Early Cash Value product available to individual buyers in every state?

The most relevant MassMutual offer for this use case is Whole Life Legacy High Early Cash Value (HECV), with Whole Life Legacy 10 Pay and Whole Life Legacy 100 funded by paid-up additions as the main alternatives. Platforms did not agree on a single product name, and that disagreement is itself important.

Grok described a dedicated HECV policy with guaranteed cash values higher in the early years than conventional whole life, premiums payable to age 85, and a minimum face amount of $100,000 [6]. Google reported the same product family and added that Legacy HECV can place roughly 90% of the first-year premium into immediate cash value, though that figure comes from an independent review rather than a MassMutual contract illustration [9]. Anthropic cited independent material describing Whole Life Legacy High Early Cash Value as a permanent policy with a guaranteed face amount and premiums payable to age 85 [10].

OpenAI and DeepSeek were more cautious. OpenAI listed participating whole life, particularly Whole Life 10 Pay or other limited-pay designs funded with paid-up additions, and stated that exact availability of HECV, Legacy HEVC, Whole Life 100, or Legacy 100 variants is state- and underwriting-dependent [13]. DeepSeek said its official-site retrieval did not confirm a standard published product named High Early Cash Value and that no independent verification of MassMutual's early cash surrender value competitiveness versus peers was identified [14].

For a buyer, the practical takeaway is that the design matters more than the label. MassMutual's own material states that shorter-pay designs can build cash value more quickly than longer-pay designs [13]. Its published comparison shows a hypothetical 55-year-old nonsmoking male with a $250,000 Whole Life 10 Pay policy at a $22,130 annual premium and $173,588 guaranteed cash value after 10 years, versus an $8,905 annual premium and $46,588 guaranteed cash value for Whole Life 100 [16]. Those are historical hypothetical illustrations, not quotes or expected results for a new buyer.

What the AI Platforms Agreed About

Questions This Section Answers

  • What do AI platforms agree on about MassMutual for high early cash value whole life insurance?
  • Does MassMutual's dividend history make it a better choice for early cash value accumulation?

The platforms agreed on four points: MassMutual has a real early-cash-value design capability, paid-up additions are central to that design, the company's reported financial strength is top-tier, and dividends are not guaranteed.

On design, OpenAI, Anthropic, Grok, Google, and Perplexity all described participating whole life with paid-up additions or limited-pay structures as the mechanism for earlier cash value [17]. MassMutual states that dividends may be used to purchase paid-up additional insurance, increasing cash value and death benefit, and that paid-up additions are its most commonly elected dividend option [22].

On financial strength, the reported ratings were consistent across company and independent sources: A++ from A.M. Best, AA+ from S&P and Fitch, and Aa3 from Moody's [24]. Independent reviewers described these as among the highest ratings in any industry, not just insurance [27].

On dividend history, Anthropic and Kimi both cited 158 consecutive years of dividend payments since 1869 as of 2026, with a record $2.9 billion payout and a 6.60% 2026 dividend interest rate described as the highest among major mutuals for the 20th consecutive year [29]. Grok cited the same 6.60% rate [32]. MassMutual's own material states dividends have been paid every year since 1869 [33].

On the non-guarantee point, the platforms were also consistent. MassMutual states that dividends, dividend interest rates, and certain features are not guaranteed or universally available [22]. Anthropic noted that dividends are not guaranteed and are subject to significant fluctuation over the life of the policy [34]. Perplexity noted that illustrated cash values and dividends are not guaranteed [35].

Agreement among AI platforms does not prove product quality. It shows that the same public and independent sources surfaced across platforms.

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

  • Does MassMutual or Penn Mutual produce higher early cash value in years 5 to 15?
  • Is MassMutual's paid-up additions rider flexible enough for a buyer who wants to change funding amounts?

The platforms disagreed on competitive performance, product naming, and rider flexibility. These are the areas a buyer should treat as unresolved.

On competitive performance, Anthropic and Kimi both reported that Penn Mutual often produces higher actual cash values in head-to-head illustrations, especially in years 5 to 15, attributing the gap to lower internal costs and a more flexible paid-up-additions structure [37]. Kimi added that Lafayette Life typically outperforms MassMutual for maximum cash value in years 1 to 6 [39]. Anthropic also flagged an unresolved contradiction: one source described MassMutual as "above and beyond anything else on the market," while a more recent source reported Penn Mutual outperforming in head-to-head comparisons [40].

On product naming, OpenAI stated that the requested product names HECV, Legacy HEVC, and Legacy 100 were not all confirmed in current public consumer-facing materials [42]. DeepSeek reported that its official-site retrieval did not confirm a standard HECV product with published early-year cash value tables [43]. Perplexity reached a similar conclusion, noting that the exact product naming for a retail HECV offering is not consistently verifiable in the gathered sources [44].

On rider flexibility, Anthropic cited independent reviews describing MassMutual products as more rigid, with limited flexibility in paid-up-additions rider premiums [46]. Kimi described the paid-up-additions riders as among the least flexible in the industry and noted a company stance against infinite banking marketing [48]. Google reported a specific mechanical constraint: if a policyowner reduces Additional Life Insurance Rider payments for three consecutive years, the company caps the maximum allowable rider premium in future years to the highest amount paid during that drop period [49].

On the HECV target market, Kimi reported that HECV is positioned as a balance-sheet product for corporate use rather than individual wealth building, with the narrow individual case being someone who knowingly accepts weaker long-run return for maximum early liquidity [51]. Anthropic and Grok did not frame it that narrowly. This is a genuine conflict in the supplied evidence.

Use-Case-Specific Features and Capabilities

Questions This Section Answers

  • What features does MassMutual offer that support early cash value accumulation in a whole life policy?
  • Can a MassMutual policyowner access cash value through loans without reducing dividends?

MassMutual's relevant capabilities for this use case are limited-pay premium schedules, paid-up additions, policy loan access, and reported non-direct recognition loan treatment. Each has a qualification.

Limited-pay schedules are the primary lever. MassMutual describes participating whole life policies with premium schedules as short as 10 payments, and its own comparison states that shorter-pay designs generally produce higher early cash value than age-100-pay designs while requiring substantially higher premiums [52]. Kimi listed available durations including 8, 10, 12, 15, and 20 Pay, plus Legacy 65, Legacy 100, and HECV to age 85 [54].

Paid-up additions are the second lever. MassMutual states that dividends may be used to purchase paid-up additional insurance, increasing cash value and death benefit, and that paid-up additions are the most commonly elected dividend option [55]. Paid-up additions may be surrendered for cash value if not pledged as collateral [58]. Google described the Additional Life Insurance Rider as functioning as a paid-up-additions rider and the Life Insurance Supplement Rider as a term blend used to build high early cash value on standard policies [60].

Cash access is the third lever. MassMutual states that whole life cash value can typically be accessed through policy loans without a credit check, subject to available cash value and policy provisions [61]. MassMutual also states that cash value may be extracted through loans, partial surrender, or termination, and that no repayment is required for a cash value loan [62]. Kimi reported that MassMutual offers non-direct recognition loans with an adjustable rate, meaning dividends are not reduced when policy loans are taken [63]. That specific loan-structure claim is platform-reported and should be confirmed in the contract.

The qualifications matter. MassMutual warns that policy access can reduce benefits and increase lapse or tax risk, and that overly rapid funding can create Modified Endowment Contract treatment [64]. Loans and withdrawals can reduce cash value and death benefit and increase lapse and tax risk [64]. Early cash surrender values are typically lower than premiums paid because of acquisition and surrender charges, so high early cash value depends on design specifics rather than being an automatic feature [65].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

  • How much does MassMutual whole life insurance cost per month for a high early cash value design?
  • What fees and rider charges apply to a MassMutual high early cash value policy?

No current individualized premium or cash-value quote can be verified from public materials, and pricing confidence across platforms was low to moderate. Pricing depends on age, underwriting, tobacco status, face amount, premium mode, state, riders, and the selected base-plus-paid-up-additions design [66].

The clearest cost signal is the premium gap between short-pay and long-pay designs. In MassMutual's own hypothetical, a 10-pay design carried a $22,130 annual premium versus $8,905 for Whole Life 100, with guaranteed cash value after 10 years of $173,588 versus $46,588 [67]. Grok cited an HECV example of roughly $14,300 annual premium for $1 million of face coverage for a 35-year-old male, and noted premiums are payable to age 85 for the HECV base [68]. These are illustrative examples, not quotes.

On fees, Grok reported an Additional Life Insurance Rider expense charge of 7.5% to 10% per payment, guaranteed not to exceed that range, plus administrative fees for certain riders [68]. Google reported a policy fee embedded in basic illustrations and mortality and expense charges deducted from rider payments before converting to paid-up additions [69]. Anthropic listed additional installment charges for monthly or semi-annual payment instead of annual, plus rider charges for Waiver of Premium, Guaranteed Insurability, Accelerated Death Benefit, Transfer of Insured, and face amount increase processing [70]. OpenAI stated that specific rider charges, loan interest rates, surrender charges, and administrative charges were not verified in the reviewed public sources [66].

On contract terms, Anthropic reported that Whole Life Legacy 10 Pay is paid up after 10 years, Whole Life Legacy 100 uses level premiums to age 100 or death, and HECV is guaranteed paid up at age 85 with premiums payable to age 85 [71]. Cash surrender is allowed at any time, policy loans are available against cash value up to predetermined limits, and non-forfeiture options include cash value payout, reduced paid-up insurance, or extended term insurance [70]. Surrender, lapse, or policy termination can reduce benefits and may create taxable income [66].

On dividend assumptions, MassMutual's illustration guidance distinguishes guaranteed values from non-guaranteed values based on potential dividends and paid-up additions [73]. The reported dividend interest rate is a company-reported, non-guaranteed figure and is not equivalent to a policy investment return [74].

Best Suited For

Questions This Section Answers

  • Who is MassMutual best suited for when early cash value is the priority?
  • Is MassMutual a good fit for a buyer who can commit to high limited-pay premiums?

MassMutual is best suited for buyers who can commit to materially higher premiums for a limited-pay design and who want participating whole life with dividends directed to paid-up additions. OpenAI's fit assessment listed buyers willing to pay materially higher premiums for a 10-pay or other limited-pay design, buyers who want dividends directed toward paid-up additions, buyers who value insurer financial strength and long-term policy continuity, and buyers willing to compare guaranteed values separately from non-guaranteed dividend assumptions [75].

Anthropic added buyers who prioritize early cash value accessibility and accept lower long-term growth, applicants seeking maximum financial strength, individuals valuing the 158-year dividend payment history and mutual structure, buyers wanting Whole Life Legacy 10 Pay for rapid premium payoff with continued compounding, and clients willing to work with financial professionals on custom policy design with paid-up additions [76].

Kimi framed the best-fit buyer more narrowly: someone who wants maximum insurer financial strength and is willing to trade some policy design flexibility for stability, businesses using HECV for executive benefit or key person strategies, buyers who value non-direct recognition policy loans, and buyers with very long time horizons of 30 years or more [79].

Google's best-fit list was similar but emphasized discipline: consumers wanting a highly established mutual company with a strong dividend track record, corporate or executive selective benefits needing roughly 90% first-year cash value liquidity through Legacy HECV, and disciplined funders who can reliably commit to structured premium schedules without needing frequent adjustments [80].

Probably Not Best Suited For

Questions This Section Answers

  • Who should not choose MassMutual for Whole Life Insurance for High Early Cash Value?
  • Is MassMutual a poor fit for a buyer who needs flexible paid-up additions funding?

MassMutual is probably not the best fit for buyers who need flexible paid-up-additions funding, buyers seeking the lowest-cost death benefit, and buyers who need predictable liquid returns comparable to a conventional investment account.

OpenAI listed buyers seeking the lowest-cost death benefit, buyers unable to sustain high early premiums, buyers who need predictable liquid returns comparable to a conventional investment account, and buyers whose primary objective is short-term liquidity rather than permanent insurance [82].

Anthropic listed buyers seeking maximum cash value growth across all policy years, applicants prioritizing flexible paid-up-additions rider design and cost control, those requiring fully digital online application and instant quotes, buyers optimizing for lowest net cost basis relative to early cash value, and individuals with a strong preference for policy cost transparency without agent consultation [83].

Kimi listed consumers focused on maximizing cash value in years 5 to 15, consumers needing maximum early cash value in years 1 to 6, buyers wanting highly flexible paid-up-additions riders with catch-up provisions, self-directed infinite banking practitioners seeking carrier alignment with that strategy, and price-sensitive buyers seeking lowest-cost whole life or term alternatives [86].

Google listed entrepreneurs or fluctuating-income buyers who need highly flexible, easily adjustable paid-up-additions funding, and buyers looking for agents explicitly trained in and supportive of infinite banking or cash flow optimization, citing MassMutual's strict marketing rules [88].

When Another Option May Be Better

Questions This Section Answers

  • What is a better alternative to MassMutual for a buyer who needs maximum cash value in years 5 to 15?
  • When is a term policy plus separate investments better than a MassMutual high early cash value policy?

Another option may be better in four situations: when a competing illustration shows higher guaranteed and non-guaranteed early cash value at the same premium and face amount, when the buyer mainly needs inexpensive death benefit protection, when liquidity and transparency matter more than lifetime death-benefit guarantees, and when MassMutual's base policy, rider, loan terms, or state availability do not meet the target.

OpenAI stated that another participating mutual insurer is better when its current illustration shows higher guaranteed and non-guaranteed early cash value at the same premium, face amount, underwriting class, and policy duration, and that a lower-cost term policy plus separate investments is better when the buyer primarily needs inexpensive death-benefit protection rather than permanent insurance and cash-value accumulation [89].

Anthropic and Kimi both named specific competitors by year window. Penn Mutual often produces higher actual cash value in head-to-head illustrations, especially in years 5 to 15, according to independent practitioner reporting [90]. Lafayette Life typically outperforms MassMutual for maximum cash value in years 1 to 6 [91]. Anthropic recommended running side-by-side illustrations before assuming MassMutual's higher headline dividend rate translates to higher performance [92].

Perplexity framed the alternative condition around verifiability: choose another insurer if the buyer wants a published, easily verifiable HECV illustration with clearly documented first-year cash value, or if the buyer wants the highest possible guaranteed cash value efficiency and is willing to compare carriers and illustrations extensively [93].

Grok noted that a standard Whole Life 100 design may be better when lowest long-term cost or maximum death benefit per premium is the priority over early cash value [95].

Questions to Verify Before Buying

Questions This Section Answers

  • What should a buyer confirm with MassMutual before signing a high early cash value whole life contract?
  • How can a buyer verify that a MassMutual illustration is not overstating early cash value?

The platforms produced a consistent verification list. The recurring items are the exact policy form and state version, guaranteed versus non-guaranteed values, the base-to-rider premium split, loan terms, surrender charges, and Modified Endowment Contract status.

On product identity, OpenAI advised confirming the exact policy form, state-specific version, base face amount, and premium period being proposed, and whether the exact product and rider combination is available in the buyer's state and under the buyer's underwriting class [96]. DeepSeek asked whether MassMutual offers a specific Whole Life High Early Cash Value product or whether it is a custom design [97]. Perplexity asked which exact product form is being quoted: standard participating whole life, Whole Life 10 Pay, Legacy/HECV, or another variant [98].

On values, OpenAI advised requesting guaranteed cash value, guaranteed death benefit, and surrender value at years 1 through 15, plus the illustrated non-guaranteed values and the dividend assumptions driving them [96]. Perplexity asked for first-year and year-5 cash values and the dividend assumptions used, plus an in-force illustration showing cash value under reduced dividend scenarios [98]. Kimi asked for illustrated 7-year and 15-year cash value projections for HECV versus Legacy 10 Pay with paid-up additions, compared against Lafayette Life and Penn Mutual illustrations for the same premium [99].

On funding mechanics, OpenAI asked how much of the planned premium funds base coverage versus paid-up additions, and whether the paid-up-additions option is contractual, discretionary, or subject to underwriting and company approval [96]. Google asked for the exact ratio of base premium to Additional Life Insurance Rider in the illustration and whether it is structured to avoid Modified Endowment Contract status, plus what happens to cash value and death benefit if the rider premium is skipped or dramatically reduced for more than two years [100].

On loans and surrender, OpenAI asked for current and guaranteed loan rates, direct-recognition rules, and the effects of loans on dividends, plus the surrender-charge schedule and what happens if premiums stop early [96]. Perplexity asked for the current policy loan interest rate, direct versus participating loan treatment, and any loan spreads or floor rates [98]. Kimi asked to verify the current loan interest rate and historical adjustment patterns for non-direct recognition loans [99].

On tax treatment, OpenAI asked whether the proposed funding will cause a Modified Endowment Contract [96]. Kimi asked to confirm MEC testing for any high early cash value design to avoid loss of favorable tax treatment [99].

Final AI Consensus Verdict

MassMutual is a good fit for Whole Life Insurance for High Early Cash Value, with meaningful qualification. Four of seven platforms named it during ranking, with an average listed rank of 2.25 and a best rank of 1. Six of seven platforms rated the fit as good or strong; Kimi rated it mixed.

The case for MassMutual rests on a purpose-built high-early-cash-value design, participating whole life with paid-up additions, reported top-tier financial strength, and a long dividend payment history. The case against relying on it without comparison rests on independent reports that Penn Mutual often produces higher actual cash values in years 5 to 15 and Lafayette Life in years 1 to 6, on descriptions of MassMutual's paid-up-additions rider as comparatively rigid, and on unresolved questions about exact product naming and state availability.

The buyer should proceed only after comparing a current, state-specific illustration against at least two competing participating whole-life designs, focusing on guaranteed cash value, surrender value, premium burden, loan terms, MEC status, and early-year liquidity [101]. The broader Whole Life Insurance for High Early Cash Value comparison set provides the context for that side-by-side work, and buyers who want to weigh other permanent coverage structures can start from the life insurance category directory.

How This Review Was Produced

This review used only the supplied platform research responses, the entity ranking statistics, and the citation source catalog. Seven platforms were included: anthropic, deepseek, google, grok, kimi, openai, and perplexity. Each platform was asked which whole life insurance carriers it would recommend for a buyer prioritizing accessible cash value in the early years of the policy, and each returned a fit assessment, use-case findings, pricing and terms, limitations, and verification questions.

Platform mentions in the ranking stage count only platforms that named MassMutual during ranking discovery. All included platforms evaluated fit, but not all named the entity in their ranked lists. The study research date is 2026-09-20.

Methodology Limitations

Several limitations apply. Platform-reported research dates differ from the authoritative run date: deepseek reported 2026-06-15, while the other six platforms reported 2026-09-21. Those dates are provenance metadata and do not independently prove freshness.

The supplied URLs were collected from platform responses and were not independently validated by the writer stage. Citations are platform-reported evidence, not independently verified facts. DeepSeek ran with search disabled, so its claims require explicit verification before being described as current facts.

Official-site retrieval for massmutual.com failed with a read timeout, so no official-page excerpt was available to confirm product naming, availability, or current pricing. The deterministic identity audit noted that official-site retrieval failed for one or more mentions, that identity matching used an exact-name fallback with the reported domain retained but unverified, and that company-name variants were collapsed onto one canonical brand before minimum-mentions qualification.

Conflicting product names, pricing, and capabilities were not resolved by guessing. Where platforms disagreed, the conflict is described and the buyer is directed to verify. No current public fee schedule or individualized quote was verified, and the cited numerical examples are historical hypotheticals that cannot substitute for a current personalized illustration.

Sources

Company-Owned Sources

  • How to borrow from your whole life insurance policy: https://blog.massmutual.com/insurance/borrow-life-insurance-loan
  • Cash value life insurance loans: Pros and cons: https://blog.massmutual.com/insurance/life-insurance-cash-value-care
  • Life insurance and the power of the illustration: https://blog.massmutual.com/insurance/life-insurance-illustration
  • How whole life insurance can balance protection and accumulation: https://blog.massmutual.com/insurance/whole-life-protection-accumulation
  • Short vs. long premium policies: The cash value difference: https://blog.massmutual.com/insurance/wholelife-premium-policies
  • Dividend Difference Landing Page: https://mmsd.massmutual.com/dividend-difference-lp
  • Insurance Ratings & Financial Strength - MassMutual: https://www.massmutual.com/about-us/massmutual-financial-summary
  • Additional AI research evidence101 records
    1. AI research evidence record deepseek:c1
    2. AI research evidence record perplexity:1
    3. AI research evidence record openai:c6
    4. AI research evidence record anthropic:2-15
    5. AI research evidence record anthropic:2-16
    6. AI research evidence record grok:0
    7. AI research evidence record grok:1
    8. AI research evidence record grok:7
    9. AI research evidence record google:1.1.7
    10. AI research evidence record anthropic:4-12
    11. AI research evidence record anthropic:4-14
    12. AI research evidence record anthropic:4-15
    13. AI research evidence record openai:c1
    14. AI research evidence record deepseek:c1
    15. AI research evidence record deepseek:c3
    16. AI research evidence record openai:c2
    17. AI research evidence record openai:c1
    18. AI research evidence record anthropic:2-4
    19. AI research evidence record grok:2
    20. AI research evidence record google:1.2.2
    21. AI research evidence record perplexity:1
    22. AI research evidence record openai:c3
    23. AI research evidence record anthropic:12-16
    24. AI research evidence record openai:c6
    25. AI research evidence record anthropic:2-15
    26. AI research evidence record anthropic:44-11
    27. AI research evidence record anthropic:2-16
    28. AI research evidence record anthropic:33-7
    29. AI research evidence record anthropic:23-13
    30. AI research evidence record anthropic:44-1
    31. AI research evidence record kimi:mm-iande-2026
    32. AI research evidence record grok:18
    33. AI research evidence record anthropic:12-7
    34. AI research evidence record anthropic:11-10
    35. AI research evidence record perplexity:2
    36. AI research evidence record perplexity:5
    37. AI research evidence record anthropic:43-4
    38. AI research evidence record anthropic:43-5
    39. AI research evidence record kimi:mm-iande-2026
    40. AI research evidence record anthropic:43-3
    41. AI research evidence record anthropic:43-15
    42. AI research evidence record openai:c1
    43. AI research evidence record deepseek:c1
    44. AI research evidence record perplexity:4
    45. AI research evidence record perplexity:15
    46. AI research evidence record anthropic:7-14
    47. AI research evidence record anthropic:7-15
    48. AI research evidence record kimi:mm-betterwealth-cashvalue-2026
    49. AI research evidence record google:2.1.8
    50. AI research evidence record google:2.2.7
    51. AI research evidence record kimi:mm-tipblog-2026
    52. AI research evidence record openai:c1
    53. AI research evidence record openai:c2
    54. AI research evidence record kimi:mm-fmiagent-2026
    55. AI research evidence record openai:c3
    56. AI research evidence record anthropic:12-16
    57. AI research evidence record perplexity:1
    58. AI research evidence record perplexity:2
    59. AI research evidence record perplexity:5
    60. AI research evidence record google:1.2.2
    61. AI research evidence record perplexity:11
    62. AI research evidence record perplexity:14
    63. AI research evidence record kimi:mm-iande-2026
    64. AI research evidence record openai:c5
    65. AI research evidence record deepseek:c2
    66. AI research evidence record openai:c1
    67. AI research evidence record openai:c2
    68. AI research evidence record grok:1
    69. AI research evidence record google:2.1.8
    70. AI research evidence record anthropic:2-2
    71. AI research evidence record anthropic:2-4
    72. AI research evidence record anthropic:4-15
    73. AI research evidence record openai:c4
    74. AI research evidence record openai:c3
    75. AI research evidence record openai:c1
    76. AI research evidence record anthropic:2-5
    77. AI research evidence record anthropic:19-2
    78. AI research evidence record anthropic:23-13
    79. AI research evidence record kimi:mm-iande-2026
    80. AI research evidence record google:1.1.7
    81. AI research evidence record google:2.1.8
    82. AI research evidence record openai:c1
    83. AI research evidence record anthropic:37-8
    84. AI research evidence record anthropic:45-4
    85. AI research evidence record anthropic:45-5
    86. AI research evidence record kimi:mm-iande-2026
    87. AI research evidence record kimi:mm-betterwealth-cashvalue-2026
    88. AI research evidence record google:2.1.8
    89. AI research evidence record openai:c1
    90. AI research evidence record anthropic:43-4
    91. AI research evidence record kimi:mm-iande-2026
    92. AI research evidence record anthropic:43-14
    93. AI research evidence record perplexity:4
    94. AI research evidence record perplexity:15
    95. AI research evidence record grok:1
    96. AI research evidence record openai:c1
    97. AI research evidence record deepseek:c1
    98. AI research evidence record perplexity:4
    99. AI research evidence record kimi:mm-iande-2026
    100. AI research evidence record google:2.1.8
    101. AI research evidence record openai:c1

Independent Sources

Other Sources

  • Additional AI research evidence101 records
    1. AI research evidence record deepseek:c1
    2. AI research evidence record perplexity:1
    3. AI research evidence record openai:c6
    4. AI research evidence record anthropic:2-15
    5. AI research evidence record anthropic:2-16
    6. AI research evidence record grok:0
    7. AI research evidence record grok:1
    8. AI research evidence record grok:7
    9. AI research evidence record google:1.1.7
    10. AI research evidence record anthropic:4-12
    11. AI research evidence record anthropic:4-14
    12. AI research evidence record anthropic:4-15
    13. AI research evidence record openai:c1
    14. AI research evidence record deepseek:c1
    15. AI research evidence record deepseek:c3
    16. AI research evidence record openai:c2
    17. AI research evidence record openai:c1
    18. AI research evidence record anthropic:2-4
    19. AI research evidence record grok:2
    20. AI research evidence record google:1.2.2
    21. AI research evidence record perplexity:1
    22. AI research evidence record openai:c3
    23. AI research evidence record anthropic:12-16
    24. AI research evidence record openai:c6
    25. AI research evidence record anthropic:2-15
    26. AI research evidence record anthropic:44-11
    27. AI research evidence record anthropic:2-16
    28. AI research evidence record anthropic:33-7
    29. AI research evidence record anthropic:23-13
    30. AI research evidence record anthropic:44-1
    31. AI research evidence record kimi:mm-iande-2026
    32. AI research evidence record grok:18
    33. AI research evidence record anthropic:12-7
    34. AI research evidence record anthropic:11-10
    35. AI research evidence record perplexity:2
    36. AI research evidence record perplexity:5
    37. AI research evidence record anthropic:43-4
    38. AI research evidence record anthropic:43-5
    39. AI research evidence record kimi:mm-iande-2026
    40. AI research evidence record anthropic:43-3
    41. AI research evidence record anthropic:43-15
    42. AI research evidence record openai:c1
    43. AI research evidence record deepseek:c1
    44. AI research evidence record perplexity:4
    45. AI research evidence record perplexity:15
    46. AI research evidence record anthropic:7-14
    47. AI research evidence record anthropic:7-15
    48. AI research evidence record kimi:mm-betterwealth-cashvalue-2026
    49. AI research evidence record google:2.1.8
    50. AI research evidence record google:2.2.7
    51. AI research evidence record kimi:mm-tipblog-2026
    52. AI research evidence record openai:c1
    53. AI research evidence record openai:c2
    54. AI research evidence record kimi:mm-fmiagent-2026
    55. AI research evidence record openai:c3
    56. AI research evidence record anthropic:12-16
    57. AI research evidence record perplexity:1
    58. AI research evidence record perplexity:2
    59. AI research evidence record perplexity:5
    60. AI research evidence record google:1.2.2
    61. AI research evidence record perplexity:11
    62. AI research evidence record perplexity:14
    63. AI research evidence record kimi:mm-iande-2026
    64. AI research evidence record openai:c5
    65. AI research evidence record deepseek:c2
    66. AI research evidence record openai:c1
    67. AI research evidence record openai:c2
    68. AI research evidence record grok:1
    69. AI research evidence record google:2.1.8
    70. AI research evidence record anthropic:2-2
    71. AI research evidence record anthropic:2-4
    72. AI research evidence record anthropic:4-15
    73. AI research evidence record openai:c4
    74. AI research evidence record openai:c3
    75. AI research evidence record openai:c1
    76. AI research evidence record anthropic:2-5
    77. AI research evidence record anthropic:19-2
    78. AI research evidence record anthropic:23-13
    79. AI research evidence record kimi:mm-iande-2026
    80. AI research evidence record google:1.1.7
    81. AI research evidence record google:2.1.8
    82. AI research evidence record openai:c1
    83. AI research evidence record anthropic:37-8
    84. AI research evidence record anthropic:45-4
    85. AI research evidence record anthropic:45-5
    86. AI research evidence record kimi:mm-iande-2026
    87. AI research evidence record kimi:mm-betterwealth-cashvalue-2026
    88. AI research evidence record google:2.1.8
    89. AI research evidence record openai:c1
    90. AI research evidence record anthropic:43-4
    91. AI research evidence record kimi:mm-iande-2026
    92. AI research evidence record anthropic:43-14
    93. AI research evidence record perplexity:4
    94. AI research evidence record perplexity:15
    95. AI research evidence record grok:1
    96. AI research evidence record openai:c1
    97. AI research evidence record deepseek:c1
    98. AI research evidence record perplexity:4
    99. AI research evidence record kimi:mm-iande-2026
    100. AI research evidence record google:2.1.8
    101. AI research evidence record openai:c1

Verify this research

Check when the research was run, which platforms were included, and what supports the findings.

Study date
September 20, 2026
Platforms analyzed
7
Source records
46
Ranking mentions
4 of 7
Platform share
57%
Final consensus rank
#5

Behind the findings

Platforms in this study

  • ChatGPT
  • Claude
  • DeepSeek
  • Grok
  • Perplexity
  • Kimi
  • Gemini

Source records

29 independent · 15 company-owned · 2 unclear

Evidence support

28 direct · 5 partial

Keep in mind

Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.

Technical verification details

Use this SHA-256 fingerprint to identify the source snapshot associated with this study.

4c9380aae6298322e84d721db9ce00150c9ff6bf9e541e4fdf72fc6132fa6681